Terms: = Germ cell tumor AND BLM, MGC131620, 641, ENSG00000197299, MGC131618, RECQ2, RECQL2, RECQL3, MGC126616, BS AND Treatment
100 results:
1. Effectiveness of Carbon Ion Radiotherapy for Bone and Soft Tissue Sarcoma in Older Patients.
Kinoshita H; Yonemoto T; Yamada S; Imai R
Anticancer Res; 2024 Apr; 44(4):1773-1780. PubMed ID: 38537982
[TBL] [Abstract] [Full Text] [Related]
2. Association of tumor Treating Fields (TTFields) therapy with survival in newly diagnosed glioblastoma: a systematic review and meta-analysis.
Ballo MT; Conlon P; Lavy-Shahaf G; Kinzel A; Vymazal J; Rulseh AM
J Neurooncol; 2023 Aug; 164(1):1-9. PubMed ID: 37493865
[TBL] [Abstract] [Full Text] [Related]
3. A tumor and Immune-Related Micro-RNA Signature Predicts Relapse-Free Survival of Melanoma Patients Treated with Ipilimumab.
Kobeissi I; Eljilany I; Achkar T; LaFramboise WA; Santana-Santos L; Tarhini AA
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175874
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic value of preoperative hematological markers in patients with glioblastoma multiforme and construction of random survival forest model.
Duan X; Yang B; Zhao C; Tie B; Cao L; Gao Y
BMC Cancer; 2023 May; 23(1):432. PubMed ID: 37173662
[TBL] [Abstract] [Full Text] [Related]
5. treatment and outcome trends and predictors of overall survival of rectal melanoma: Analysis of the National Cancer Database.
Emile SH; Horesh N; Freund MR; Garoufalia Z; Gefen R; Silva-Alvarenga E; Wexner SD
Eur J Surg Oncol; 2023 Jul; 49(7):1275-1282. PubMed ID: 36732208
[TBL] [Abstract] [Full Text] [Related]
6. Electrochemotherapy of melanoma: What we know and what is unexplored?
Choromańska A; Szwedowicz U
Adv Clin Exp Med; 2023 Jan; 32(1):5-8. PubMed ID: 36637184
[TBL] [Abstract] [Full Text] [Related]
7. Fibrin glue as a local drug and photosensitizer delivery system for photochemical internalization: Potential for bypassing the blood-brain barrier.
Madsen SJ; Devarajan AG; Chandekar A; Nguyen L; Hirschberg H
Photodiagnosis Photodyn Ther; 2023 Mar; 41():103206. PubMed ID: 36414151
[TBL] [Abstract] [Full Text] [Related]
8. Vestibular schwannoma removal through expanded transcanal transpromontorial approach: a multicentric experience.
Molinari G; Calvaruso F; Presutti L; Marchioni D; Alicandri-Ciufelli M; Friso F; Fernandez IJ; Francoli P; Di Maro F
Eur Arch Otorhinolaryngol; 2023 May; 280(5):2165-2172. PubMed ID: 36208331
[TBL] [Abstract] [Full Text] [Related]
9. Proton beam therapy for skull base chordomas: a systematic review of tumor control rates and survival rates.
Pahwa B; Medani K; Lu VM; Elarjani T
Neurosurg Rev; 2022 Dec; 45(6):3551-3563. PubMed ID: 36181614
[TBL] [Abstract] [Full Text] [Related]
10. Endoscopic versus Nonendoscopic Surgery for Resection of Craniopharyngiomas.
Abiri A; Roman KM; Latif K; Goshtasbi K; Torabi SJ; Lehrich BM; Mohyeldin A; Hsu FPK; Kuan EC
World Neurosurg; 2022 Nov; 167():e629-e638. PubMed ID: 36041722
[TBL] [Abstract] [Full Text] [Related]
11. Associations between patient and disease characteristics and severe adverse events during immune checkpoint inhibitor treatment: An observational study.
Basak EA; Vermeer NS; de Joode K; Hurkmans DP; Velthuis DEM; Oomen-de Hoop E; Schreurs MWJ; Bins S; Koolen SLW; Debets R; van der Veldt AAM; Aerts JGJV; Joosse A; Mathijssen RHJ
Eur J Cancer; 2022 Oct; 174():113-120. PubMed ID: 35988409
[TBL] [Abstract] [Full Text] [Related]
12. ADAR3 activates NF-κB signaling and promotes glioblastoma cell resistance to temozolomide.
Raghava Kurup R; Oakes EK; Vadlamani P; Nwosu O; Danthi P; Hundley HA
Sci Rep; 2022 Aug; 12(1):13362. PubMed ID: 35922651
[TBL] [Abstract] [Full Text] [Related]
13. CT-based morphologic and radiomics features for the classification of MYCN gene amplification status in pediatric neuroblastoma.
Tan E; Merchant K; Kn BP; Cs A; Zhao JJ; Saffari SE; Tan PH; Tang PH
Childs Nerv Syst; 2022 Aug; 38(8):1487-1495. PubMed ID: 35460355
[TBL] [Abstract] [Full Text] [Related]
14. Integrative analysis of therapy resistance and transcriptomic profiling data in glioblastoma cells identifies sensitization vulnerabilities for combined modality radiochemotherapy.
Schnöller LE; Albrecht V; Brix N; Nieto AE; Fleischmann DF; Niyazi M; Hess J; Belka C; Unger K; Lauber K; Orth M
Radiat Oncol; 2022 Apr; 17(1):79. PubMed ID: 35440003
[TBL] [Abstract] [Full Text] [Related]
15. Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label, multicentre, phase 2 study.
Tawbi HA; Forsyth PA; Hodi FS; Algazi AP; Hamid O; Lao CD; Moschos SJ; Atkins MB; Lewis K; Postow MA; Thomas RP; Glaspy J; Jang S; Khushalani NI; Pavlick AC; Ernstoff MS; Reardon DA; Kudchadkar R; Tarhini A; Chung C; Ritchings C; Durani P; Askelson M; Puzanov I; Margolin KA
Lancet Oncol; 2021 Dec; 22(12):1692-1704. PubMed ID: 34774225
[TBL] [Abstract] [Full Text] [Related]
16. Automated Diagnosis and Localization of Melanoma from Skin Histopathology Slides Using Deep Learning: A Multicenter Study.
Li T; Xie P; Liu J; Chen M; Zhao S; Kang W; Zuo K; Li F
J Healthc Eng; 2021; 2021():5972962. PubMed ID: 34745503
[TBL] [Abstract] [Full Text] [Related]
17. Gamma Knife radiosurgery as primary treatment of low-grade brainstem gliomas: A systematic review and metanalysis of current evidence and predictive factors.
Gagliardi F; De Domenico P; Snider S; Pompeo E; Roncelli F; Barzaghi LR; Bailo M; Piloni M; Spina A; Fodor A; Berzero G; Di Muzio N; Filippi M; Finocchiaro G; Mortini P
Crit Rev Oncol Hematol; 2021 Dec; 168():103508. PubMed ID: 34678323
[TBL] [Abstract] [Full Text] [Related]
18. Adjuvant treatment for melanoma in clinical practice - Trial versus reality.
de Meza MM; Ismail RK; Rauwerdink D; van Not OJ; van Breeschoten J; Blokx WAM; de Boer A; van Dartel M; Hilarius DL; Ellebaek E; Bonenkamp HJ; Blank CU; Aarts MJB; van Akkooi ACJ; van den Berkmortel FWPJ; Boers-Sonderen MJ; de Groot JWB; Haanen JB; Hospers GAP; Kapiteijn EW; Piersma D; van Rijn RS; van der Veldt AAM; Vreugdenhil A; Westgeest HM; van den Eertwegh AJM; Suijkerbuijk KPM; Wouters MWJM
Eur J Cancer; 2021 Nov; 158():234-245. PubMed ID: 34600790
[TBL] [Abstract] [Full Text] [Related]
19. Management and Survival Analysis of Gastrointestinal Neuroendocrine tumors by Different tumor Characteristics: Tertiary Center Experience.
Gonulal B; Bilgic Y; Akbulut S; Karabulut E; Samdanci ET
J Gastrointest Cancer; 2022 Dec; 53(4):915-920. PubMed ID: 34524616
[TBL] [Abstract] [Full Text] [Related]
20. Differential Impact of
O'Donohue T; Gulati N; Mauguen A; Kushner BH; Shukla N; Rodriguez-Sanchez MI; Bouvier N; Roberts S; Basu E; Cheung NK; Modak S
JCO Precis Oncol; 2021; 5():. PubMed ID: 34250410
[TBL] [Abstract] [Full Text] [Related]
[Next]
